Guidance for Industry: Pharmacogenomic Data Submissions. Draft Guidance
United States. Food and Drug Administration [FDA]. Center for Drug Evaluation and Research [CDER]; Center for Biologics Evaluation and Research [CBER]; Center for Devices and Radiological Health [CDRH]
Rockville, MD: FDA, November 2003, 29 p. [Online]. Available: http://www.fda.gov/cder/guidance/5900dft.pdf [4 November 2003]
Showing items related by title, author, creator and subject.